The current valuation score of Upstream Bio Inc is 6.75, ranking 261 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.17, which is -6.18% below the recent high of -2.04 and -829.40% above the recent low of -20.21.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.